Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Elevance Health

Elevance Health (NYSE: ELV) insider transactions

In the twelve months to 10 November 2026, executives and directors of Elevance Health reported 19 open-market sales of 17,157 shares ($7.0m) and 4 open-market purchases of 6,725 shares ($2.2m), by 9 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Elevance Health shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
5 November 2026Lavu RatnakarEVP & Chief Digital Info OfrOpen-market sale−1,300$440.0014,849Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−400$434.0030,103Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−321$435.2529,782Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−160$444.8521,019Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−827$446.0520,192Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−273$447.1919,919Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−1,660$436.2028,122Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−560$437.0727,562Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−240$438.2227,322Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−1,160$439.2526,162Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−1,720$440.4424,442Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−2,343$441.3422,099Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−480$442.6121,619Form 4
22 October 2026Kaye MarkEVP & CFOOpen-market sale−440$443.8121,179Form 4
2 October 2026Kaye MarkEVP & CFOShares withheld for tax−4,161$386.4327,876Form 4
2 October 2026Kaye MarkEVP & CFOGrant or award+2,627—30,503Form 4
3 September 2026Wessling Erin MEVP & Chief Legal OfficerShares withheld for tax−255$414.787,230Form 4
2 September 2026Craig Ryan REVP & Chief HR OfficerShares withheld for tax−144$405.846,530Form 4
2 September 2026Wessling Erin MEVP & Chief Legal OfficerShares withheld for tax−94$405.847,485Form 4
17 July 2026Peru Ramiro GDirectorOpen-market purchase+1,000$366.0510,908Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Elevance Health page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.